Genetic approaches to the cellular functions of polyamines in mammals

European Journal of Biochemistry

Volumn 271, Issue 5, 2004, Pages 877-894

  Jänne, Juhani ^a   Alhonen, Leena ^a   Pietilä, Marko ^a   Keinänen, Tuomo A ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antizyme; Ornithine decarboxylase; Putrescine; Spermidine; Spermidine spermine N 1 acetyltransferase; Spermine; Transgenic mouse; Transgenic rat

Indexed keywords

ACYLTRANSFERASE; ADENOSYLMETHIONINE DECARBOXYLASE; ALPHA METHYLSPERMIDINE; ARGINASE; ARGININE; EFLORNITHINE; ENZYME ANTIBODY; ETOPOSIDE; GOSSYPOL; IFENPRODIL; MITOGUAZONE; N BENZYL N METHYLNITROSAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N1 ACETYLSPERMIDINE; N1,N11 DIETHYLNORSPERMINE; NEUROTROPHIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORNITHINE; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITOR; POLYAMINE; POLYAMINE OXIDASE; PUTRESCINE; SPERMIDINE; SPERMIDINE DERIVATIVE; SPERMIDINE SPERMINE N1 ACETYLTRANSFERASE; SPERMINE; SPERMINE SYNTHASE; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; APOPTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; CARCINOGENESIS; CATALYSIS; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CLINICAL TRIAL; DEACETYLATION; DECARBOXYLATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME SUBSTRATE; FEMALE INFERTILITY; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC ENGINEERING; HAIR LOSS; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; LIVER REGENERATION; MALE INFERTILITY; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PANCREAS; PANCREATITIS; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN PAPILLOMA; SPERMATOGENESIS; TRANSCRIPTION REGULATION; TRANSGENE;

ACETYLTRANSFERASES; ADENOSYLMETHIONINE DECARBOXYLASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARDIOMEGALY; HUMANS; NEOPLASMS; ORNITHINE DECARBOXYLASE; POLYAMINES; SKIN; SPERMINE SYNTHASE;

MAMMALIA; MURINAE; MUS MUSCULUS; RODENTIA;

EID: 1542284582     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04009.x     Document Type: Review

References (167)

1. Goth, T.S.T., Nagasaki, A., Terada, K., Takiguchi, M. & Mori, M. (1996) Molecular cloning of cDNA for nonhepatic mitochondrial arginase (argjnase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett. 395, 119-122.
2. 1-acetyltransferase. J. Biol. Chem. 266, 810-814.
3. Hölttä, E. (1977) Oxidation of spermidine and spermine in rat liver: purification and properties of polyamine oxidase. Biochemistry 16, 91-100.
4. 1-acetyltransferase - the turning point in polyamine metabolism. FASEB J. 7, 653-661.
5. 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J. Biol. Chem. 275, 38319-38328.
6. 1-acetyltransferase gene in mouse embryonic stem cells. Effects on polyamine homeostasis and sensitivity to polyamine analogues. J. Biol. Chem. 277, 25323-25328.
7. Wang, Y., Devereux, W., Woster, P.M., Stewart, T.M., Hacker, A. & Casero, R.A. Jr (2001) Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res. 61, 5370-5373.
8. Vujcic, S., Diegelman, P., Bacchi, C.J., Kramer, D.L. & Porter, C.W. (2002) Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin. Biochem. J. 367, 665-675.
9. Wang, Y., Murray-Stewart, T., Devereux, W., Hacker, A., Frydman, B., Woster, P.M. & Casero, R.A. Jr (2003) Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem. Biophys. Res. Commun. 304, 605-611.
10. Park, M.H., Cooper, H.L. & Folk, J.E. (1981) Identification of hypusine, an unusual amino acid, in protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc. Natl Acad. Sci. USA 78, 2869-2873.
11. Park, M.H., Wolff, E.C. & Folk, J.E. (1993) Is hypusine essential for eukaryotic cell proliferation? Trends Biochem. Sci. 18, 475-479.
12. Fong, W.F., Heller, J.S. & Canellakis, E.S. (1976) The appearance of an ornithine decarboxylase inhibitory protein upon the addition of putrescine to cell cultures. Biochim. Biophys. Acta 428, 456-465.
13. Heller, J.S., Fong, W.F. & Canellakis, E.S. (1976) Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Proc. Natl Acad. Sci. USA 73, 1858-1862.
14. McCann, P.P., Tardif, C. & Mamont, P.S. (1977) Regulation of ornithine decarboxylase by ODC-antizyme in HTC cells. Biochem. Biophys. Res. Commun. 75, 948-954.
15. Hayashi, S., Murakami, Y. & Matsufuji, S. (1996) Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem. Sci. 21, 27-30.
16. Coffino, P. (2001) Antizyme, a mediator of ubiquitin-independent proteasomal degradation. Biochimie 83, 319-323.
17. Mitchell, J.L.A., Judd, G.G., Bareyal-Leyser, A. & Ling, S.Y. (1994) Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue-culture cells. Biochem. J. 299, 19-22.
18. Matsufuji, S., Matsufuji, T., Miyazaki, Y., Murakami, Y., Atkins, J.F., Gesteland, R.F. & Hayashi, S.-I. (1995) Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 80, 51-60.
19. Rom, E. & Kahana, C. (1994) Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. Proc. Natl Acad. Sci. USA 91, 3959-3963.
20. Gritli-Linde, A., Nilsson, J., Bohlooly, Y.M., Heby, O. & Linde, A. (2001) Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated. Dev. Dyn. 220, 259-275.
21. Murai, N., Murakami, Y. & Matsufuji, S. (2003) Identification of nuclear export signals in antizyme-1. J. Biol. Chem. 278, 44791-44798.
22. Gruendler, C., Lin, Y., Farley, J. & Wang, T. (2001) Proteasomal degradation of Smad1 induced by bone morphogenetic proteins. J. Biol. Chem. 276, 46533-46543.
23. Lin, Y., Martin, J., Gruendler, C., Farley, J., Meng, X., Li, B.Y., Lechleider, R., Huff, C., Kim, R.H., Grasser, W.A., Paralkar, V. & Wang, T. (2002) A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs). BMC Cell Biol. 3, 15.
24. Wallace, H.M., Fraser, A.V. & Hughes, A. (2003) A perspective of polyamine metabolism. Biochem. J. 376, 1-14.
25. Seiler, N. (2003) Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr. Drug Targets 4, 565-585.
26. Seiler, N. (2003) Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr. Drug Targets 4, 537-564.
27. Jänne, J., Alhonen, L. & Leinonen, P. (1991) Polyamines: from molecular biology to clinical applications. Ann. Med. 23, 241-259.
28. Pegg, A.E., Feith, D.J., Fong, L.Y., Coleman, C.S., O'Brien, T.G. & Shantz, L.M. (2003) Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem. Soc. Trans. 31, 356-360.
29. Halmekytö, M., Hyttinen, J.-M., Sinervirta, R., Utriainen, M., Myöhänen, S., Voipio, H.-M., Wahlfors, J., Syrjänen, S., Syrjänen, K., Alhonen, L. & Jänne, J. (1991) Transgenic mice aberrantly expressing human ornithine decarboxylase gene. J. Biol. Chem. 266, 19746-19751.
30. Halmekytö, M., Alhonen, L., Wahlfors, J., Sinervirta, R., Jänne, O.A. & Jänne, J. (1991) Position-independent, aberrant expression of the human ornithine decarboxylase gene in transgenic mice. Biochem. Biophys. Res. Commun. 180, 262-267.
31. Halmekytö, M., Alhonen, L., Wahlfors, J., Sinervirta, R., Eloranta, T. & Jänne, J. (1991) Characterization of a transgenic mouse line over-expressing the human ornithine decarboxylase gene. Biochem. J. 278, 895-898.
32. Halmekytö, M., Alhonen, L., Alakuijala, L. & Jänne, J. (1993) Transgenic mice over-producing putrescine in their tissues do not convert the diamine into higher polyamines. Biochem. J. 291, 505-508.
33. Davis, R.H., Morris, D.R. & Coffino, P. (1992) Sequestered end products and enzyme regulation: The case of ornithine decarboxylase. Microbiol. Rev. 56, 280-290.
34. Hakovirta, H., Keiski, A., Toppari, J., Halmekytö, M., Alhonen, L., Jänne, J. & Parvinen, M. (1993) Polyamines and regulation of spermatogenesis: selective stimulation of late spermatogonia in transgenic mice overexpressing the human ornithine decarboxylase gene. Mol. Endocrinol. 7, 1430-1436.
35. Ivanov, I.P., Rohrwasser, A., Terreros, D.A., Gesteland, R.F. & Atkins, J.F. (2000) Discovery of a spermatogenesis stage-specific ornithine decarboxylase antizyme: antizyme 3. Proc. Natl Acad. Sci. USA 97, 4808-4813.
36. Coffino, P. (2000) Polyamines in spermiogenesis: not now, darling. Proc. Natl Acad. Sci. USA 97, 4421-4423.
37. Moshier, J.A., Dosescu, J., Skunca, M. & Luk, G.D. (1993) Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res. 53, 2618-2622.
38. Auvinen, M., Paasinen, A., Andersson, L.C. & Hölttä, E. (1992) Ornithine decarboxylase acitivity is critical for cell transformation. Nature 360, 355-358.
39. Auvinen, M., Laine, A., Paasinen-Sohns, A., Kangas, A., Kangas, L., Saksela, O., Andersson, L.C. & Hölttä, E. (1997) Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res. 57, 3016-3025.
40. Alhonen, L., Halmekytö, M., Kosma, V.-M., Wahlfors, J., Kauppinen, R. & Jänne, J. (1995) Life-long over-expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration. Int. J. Cancer 63, 402-404.
41. Gritli-Linde, A., Björkman, U., Holm, I., Törnell, J. & Linde, A. (1997) Effects of chronically elevated growth hormone levels on polyamine metabolism in elderly transgenic mice. Mol. Cell. Endocrinol. 126, 49-58.
42. Kilpeläinen, P.T., Saarimies, J., Kontusaari, S.I., Järvinen, M.J., Soler, A.P., Kallioinen, M.J. & Hietala, O.A. (2001) Abnormal ornithine decarboxylase activity in transgenic mice increases tumor formation and infertility. Int. J. Biochem. Cell. Biol. 33, 507-520.
43. Mitchell, J.B., Xavier, S., DeLuca, A.M., Sowers, A.L., Cook, J.A., Krishna, M.C., Hahn, S.M. & Russo, A. (2003) A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic. Biol. Med. 34, 93-102.
44. Halmekytö, M., Syrjänen, K., Jänne, J. & Alhonen, L. (1992) Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene. Biochem. Biophys. Res. Commun. 187, 493-497.
45. Megosh, L., Gilmour, S.K., Rosson, D., Soler, A.P., Blessing, M., Sawicki, J.A. & O'Brien, T.G. (1995) Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res. 55, 4205-4209.
46. Metcalf, B.W., Bey, P., Danzin, C., Jung, M.J., Casara, J. & Vevert, J.P. (1978) Catalytic irreversible inhibition of mammalian ornithine decarboxylase (EC.4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc. 100, 2551-2553.
47. Soler, A.P., Gilliard, G., Megosh, L.C. & O'Brien, T.G. (1996) Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity. J. Invest. Dermatol. 106, 1108-1113.
48. O'Brien, T.G., Megosh, L.C., Gilliard, G. & Soler, A.P. (1997) Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57, 2630-2637.
49. Soler, A.P., Gilliard, G., Megosh, L. & George, K.O.B. (1998) Polyamines regulate expression of the neoplastic phenotype in mouse skin. Cancer Res. 58, 1654-1659.
50. Smith, M.K., Trempus, C.S. & Gilmour, S.K. (1998) Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 19, 1409-1415.
51. Ahmad, N., Gilliam, A.C., Katiyar, S.K., O'Brien, T.G. & Mukhtar, H. (2001) A definitive role of ornithine decarboxylase in photocarcinogenesis. Am. J. Pathol. 159, 885-892.
52. Shantz, L.M., Guo, Y., Sawicki, J.A., Pegg, A.E. & O'Brien, T.G. (2002) Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation. Carcinogenesis 23, 657-664.
53. Hobbs, C.A. & Gilmour, S.K. (2000) High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. J. Cell. Biochem. 77, 345-360.
54. Hobbs, C.A., Paul, B.A. & Gilmour, S.K. (2002) Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors. Cancer Res. 62, 67-74.
55. de Jonge, W.J., Hallemeesch, M.M., Kwikkers, K.L., Ruijter, J.M., de Gier-de Vries, C., van Roon, M.A., Meijer, A.J., Marescau, B., de Deyn, P.P., Deutz, N.E. & Lamers, W.H. (2002) Overexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle, and lymphoid development. Am. J. Clin. Nutr. 76, 128-140.
56. Paschen, W. (1992) Polyamine metabolism in different pathological states of the brain. Mol. Chem. Neuropathol. 16, 241-271.
57. Kauppinen, R.A. & Alhonen, L.I. (1995) Transgenic animals as models in the study of the neurobiological role of polyamines. Progr. Neurobiol. 47, 545-563.
58. Williams, K., Romano, C. & Molinoff, P.B. (1989) Effects of polyamines on the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol. Pharmacol. 36, 575-581.
59. Williams, K., Dawson, V.L., Romano, C., Dichter, M.A. & Molinoff, P.B. (1990) Characterization of polyamines having agonist, antagonist, and inverse effects at the polyamine recognition site of the NMDA receptor. Neuron 5, 199-208.
60. Halonen, T., Sivenius, J., Miettinen, R., Halmekytö, M., Kauppinen, R., Sinervirta, R., Alakuijala, L., Alhonen, L., MacDonald, E., Jänne, J., et al. (1993) Elevated seiqure threshold and impaired spatial learning in transgenic mice with putrescine overproduction in the brain. Eur. J. Neurosci. 5, 1233-1239.
61. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. & Prochiantz, A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307, 462-465.
62. 2+ concentration in the brain of transgenic mice overexpressing human ornithine decarboxylase gene. J. Neurochem. 58, 831-836.
63. Mody, I. & Heinemann, U. (1987) NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling. Nature 326, 701-704.
64. O'Keefe, J. & Speakman, A. (1987) Single unit activity in the rat hippocampus during a spatial memory task. Exp. Brain Res. 68, 1-27.
65. Reeben, M., Arbatova, J., Palgi, J., Miettinen, R., Halmekytö, M., Alhonen, L., Jänne, J., Riekkinen, P. Sr & Saarma, M. (1996) Induced expression of neurotrophins in transgenic mice over-expressing ornithine decarboxylase and overproducing putrescine. J. Neurosci. Res. 45, 542-548.
66. Lukkarinen, J., Kauppinen, R.A., Koistinaho, J., Halmekytö, M., Alhonen, L. & Jänne, J. (1995) Cerebral energy metabolism and immediate early gene induction following severe incomplete ischaemia in transgenic mice overexpressing the human ornithine decarboxylase gene: evidence that putrescine is not neurotoxic in vivo. Eur. J. Neurosci. 7, 1840-1849.
67. Lukkarinen, J., Gröhn, O., Sinervirta, R., Järvinen, A., Kauppinen, R.A., Jänne, J. & Alhonen, L. (1997) Transgenic rats as models for studying the role of ornithine decarboxylase expression in permanent middle cerebral artery occlusion. Stroke 28, 639-645.
68. Lukkarinen, J.A., Gröhn, O.H., Alhonen, L.I., Jänne, J. & Kauppinen, R.A. (1999) Enhanced ornithine decarboxylase activity is associated with attenuated rate of damage evolution and reduction of infarct volume in transient middle cerebral artery occlusion in the rat. Brain Res. 826, 325-329.
69. Lukkarinen, J.A., Kauppinen, R.A., Gröhn, O.H.J., Oja, J.M.E., Sinervirta, R., Alhonen, L.I. & Jänne, J. (1998) Neuroprotective role of ornithine decarboxylase activation in transient cerebral focal ischemia: a study using ornithine decarboxylase-over-expressing transgenic rats. Eur. J. Neurosci. 10, 2046-2055.
70. Pegg, A.E. & Hibasami, H. (1980) Polyamine metabolism during cardiac hypertrophy. Am. J. Physiol. 239, E372-E378.
71. Cubria, J.C., Reguera, R., Balana-Fouce, R., Ordonez, C. & Ordonez, D. (1998) Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse. J. Pharm. Pharmacol. 50, 91-96.
72. Pegg, A.E. (1981) Effect of alpha-difluoromethylornithine on cardiac polyamine content and hypertrophy. J. Mol. Cell. Cardial. 13, 881-887.
73. Shantz, L.M., Feith, D.J. & Pegg, A.E. (2001) Targeted over-expression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy. Biochem. J. 358, 25-32.
74. Lopatin, A.N., Makhina, E.N. & Nichols, C.G. (1994) Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 372, 366-369.
75. + channels is caused by intracellular spermine. Cell 80, 149-154.
76. Lopatin, A.N., Shantz, L.M., Mackintosh, C.A., Nichols, C.G. & Pegg, A.E. (2000) Modulation of potassium channels in the hearts of transgenic and mutant mice with altered polyamine biosynthesis. J. Mol. Cell. Cardiol. 32, 2007-2024.
77. Heljasvaara, R., Veress, I., Halmekytö, M., Alhonen, L., Jänne, J., Laajala, P. & Pajunen, A. (1997) Transgenic mice over-expressing ornithine and S-adenosylmethionine decarboxylases maintain a physiological polyamine homeostasis in their tissues. Biochem. J. 323, 457-462.
78. Kauppinen, L., Myöhänen, S., Halmekytö, M., Alhonen, L. & Jänne, J. (1993) Transgenic mice over-expressing the human spermidine synthase gene. Biochem. J. 293, 513-516.
79. 1-acetyltransferase. J. Biol. Chem. 272, 18746-18751.
80. Suppola, S., Heikkinen, S., Parkkinen, J.J., Uusi-Oukari, M., Korhonen, V.P., Keinänen, T., Alhonen, L. & Jänne, J. (2001) Concurrent overexpression of ornithine decarboxylase and spermidine/spermine N1-acetyltransferase further accelerates the catabolism of hepatic polyamines in transgenic mice. Biochem. J. 358, 343-348.
81. 1-acetyltransferase in MALME-3M human melanoma cells. J. Biol. Chem. 268, 19118-19125.
82. 1-acetyltransferase (SSAT) gene in human lung carcinoma cells. Biochem. J. 313, 691-696.
83. 12-bis(ethyl)spermine. Biochem. J. 305, 451-458.
84. 1-acetyltransferase by polyamines. FEBS Lett. 391, 89-94.
85. Libby, P.R., Bergeron, R.J. & Porter, C.W. (1989) Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity. Biochem. Pharmacol. 38, 1435-1442.
86. 1- acetyltransferase. J. Biol. Chem. 273, 1964-1969.
87. 1-acetyltransferase under the control of mouse metallothionein I promoter in transgenic mice: evidence for a striking post-transcriptional regulation of transgene expression by a polyamine analogue. Biochem. J. 338, 311-316.
88. 1- acetyltransferase mRNA in the human kidney cells infected by venezuelan equine encephalitis and tick-borne encephalitis viruses. Virology 297, 163-171.
89. 11-diethylnorspermine in patients with non-small cell lung cancer. Clin. Cancer Res. 8, 684-690.
90. 1-acetyltransferase in human lung cancer cells by the bis(ethyl) polyamine analogues. Cancer Res. 49, 3829-3833.
91. 1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res. 51, 3715-3720.
92. 12- bis(ethyl)spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. Anticancer Res. 12, 1083-1090.
93. 12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res. 52, 5359-5363.
94. 12-diethylnorspermine. Mol. Pharmacol. 55, 693-698.
95. 1-acetyltransferase. Mol. Pharmacol. 64, 1153-1159.
96. 1-acetyltransferase. J. Invest. Dermatol. 116, 801-805.
97. 1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis. Carcinogenesis 23, 359-364.
98. 1-acetyltransferase (SSAT). J. Biol. Chem. 277, 3647-3657.
99. Rosenthal, S.M. & Tabor, C.W. (1956) The pharmacology of spermine and spermidine. Distribution and excretion. J. Pharmacol. Exp. Ther. 116, 131-138.
100. Löser, C., Fölsch, U.R., Cleffmann, U., Nustede, R. & Creuzfeldt, W. (1989) Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats. Digestion 43, 98-112.
101. Morisset, J. & Grondin, G. (1987) Implication of ornithine decarboxylase and polyamines in pancreatic growth of neonatal rats. Pancreas 2, 303-311.
102. Haarstad, H., Skei, T. & Petersen, H. (1989) Inhibition of polyamine synthesis by α-difluoromethyl-ornithine and its effect on pancreatic secretion and growth in the rat. Scand. J. Gastroenterol. 24, 733-744.
103. Alhonen, L., Parkkinen, J.J., Keinänen, T., Sinervirta, R., Herzig, K.H. & Jänne, J. (2000) Activation of polyamine catabolism in transgenic rats induces acute pancreatitis. Proc. Natl Acad. Sci. USA 97, 8290-8295.
104. Räsänen, T.L., Alhonen, L., Sinervirta, R., Keinänen, T., Herzig, K.H., Suppola, S., Khomutov, A.R., Vepsäläinen, J. & Jänne, J. (2002) A polyamine analogue prevents acute pancreatitis and restores early liver regeneration in transgenic rats with activated polyamine catabolism. J. Biol. Chem. 277, 39867-39872.
105. Qian, S.Z. & Wang, Z.G. (1984) Gossypol: a potential antifertility agent for males. Annu. Rev. Pharmacol. Toxicol. 24, 329-360.
106. 1- acetyltransferase in canine prostate epithelial cells. Biochem. Biophys. Res. Commun. 231, 383-388.
107. 1-acetyltransferase. Scand. J. Gastroenterol. 38, 787-793.
108. Jänne, J. & Raina, A. (1968) Stimulation of spermidine synthesis in the regenerating rat liver: relation to increased ornithine decarboxylase activity. Acta Chem. Scand. 22, 1349-1351.
109. Russell, D. & Snyder, S.H. (1968) Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc. Natl Acad. Sci. USA 60, 1420-1427.
110. Jänne, J. (1967) Studies on the biosynthetic pathway of polyamines in rat liver. Acta Physiol. Scand. Supplement 300, 1-71.
111. Harik, S.I., Hollenberg, M.D. & Snyder, S.H. (1974) Alpha-hydrazino-ornithine blocks net synthesis of putrescine but not of RNA and DNA. Nature 249, 250-251.
112. Pösö, H. & Pegg, A.E. (1982) Effect of alpha- difluoromethylornithine on polyamine and DNA synthesis in regenerating rat liver. Biochim. Biophys. Acta 696, 179-186.
113. Alhonen, L., Räsänen, T.L., Sinervirta, R., Parkkinen, J.J., Korhonen, V.P., Pietilä, M. & Jänne, J. (2002) Polyamines are required for the initiation of rat liver regeneration. Biochem. J. 362, 149-153.
114. 1-acetyltransferase in transgenic mice protects the animals from kainate-induced toxicity. Eur. J. Neurosci. 12, 540-548.
115. Baudry, M. & Najm, I. (1994) Kainate-induced seizure activity stimulates the polyamine interconversion pathway in rat brain. Neurosci. Lett. 171, 151-154.
116. Choi, D.W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
117. 1-acetyltransferase elevates the threshold to pentylenetetrazol- induced seizure activity in transgenic mice. Exp. Neurol. 183, 645-652.
118. Macdonald, R.L. & Barker, J.L. (1977) Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 267, 720-721.
119. Tsuda, M., Suzuki, T. & Misawa, M. (1997) Age-related decrease in the antiseizure effect of ifenprodil against pentylenetetrazole in mice. Brain Res. Dev. Brain Res. 104, 201-204.
120. White, H.S., McCabe, R.T., Armstrong, H., Donevan, S.D., Cruz, L.J., Abogadie, F.C., Torres, J., Rivier, J.E., Paarmann, I., Hollmann, M. & Olivera, B.M. (2000) In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J. Pharmacol. Exp. Ther. 292, 425-432.
121. Gallagher, M.J., Huang, H., Pritchett, D.B. & Lynch, D.R. (1996) Interactions between ifenprodil and the NR2B subunit of the N-methyl-D- aspartate receptor. J. Biol. Chem. 271, 9603-9611.
122. Dempsey, R.J., Baskaya, M.K. & Dogan, A. (2000) Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 47, 399-404.
123. Coffino, P. (2001) Regulation of cellular polyamines by antizyme. Nat. Rev. Mol. Cell Biol. 2, 188-194.
124. Yang, D., Hayashi, H., Hiyama, Y., Takii, T. & Onozaki, K. (1995) Transfection of human melanoma cells with type I interleukin-1 (IL-1) recptor cDNA rendered them IL-1 responsive and revealed the importance of ODC activity downregulation in IL-1-induced growth inhibition. J. Biochem. 118, 802-809.
125. Tsuji, T., Todd, R., Meyer, C., McBride, J., Liao, P.H., Huang, M.F., Chou, M.Y., Donoff, R.B. & Wong, D.T.W. (1998) Reduction of ornithine decarboxylase antizyme (ODC-Az) level in the 7,12-dimethylbenz(a)anthracene- induced hamster buccal pouch carcinogenesis model. Oncogene 16, 3379-3385.
126. Smith, R.C., Litwin, M.S., Lu, Y. & Zetter, B.R. (1995) Identification of an endogenous inhibitor of prostatic carcinoma cell growth. Nat. Med. 1, 1040-1045.
127. Koike, C., Chao, D.T. & Zetter, B.R. (1999) Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells. Cancer Res. 59, 6109-6112.
128. Mackintosh, C.A., Feith, D.J., Shantz, L.M. & Pegg, A.E. (2000) Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy. Biochem. J. 350, 645-653.
129. Bartolome, J., Huguenard, J. & Slotkin, T.A. (1980) Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science 210, 793-794.
130. Feith, D.J., Shantz, L.M. & Pegg, A.E. (2001) Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res. 61, 6073-6081.
131. Weeks, C.E., Herman, A.L., Nelson, F.R. & Slaga, T.J. (1982) Alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc. Natl Acad. Sci. USA 79, 6028-6032.
132. Takigawa, M., Verm, A.K., Simsiman, R.C. & Boutwell, R.K. (1982) Polyamine biosynthesis and skin tumor promotion: inhibition of 12-o-tetra-decanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha- difluoromethylornithine. Biochem. Biophys. Res. Commun. 105, 969-976.
133. Fong, L.Y., Feith, D.J. & Pegg, A.E. (2003) Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res. 63, 3945-3954.
134. Jenkinson, C.P., Grody, W.W. & Cederbaum, S.D. (1996) Comparative properties of arginases. Comp. Biochem. Physiol. Biochem. Mol. Biol. B 114, 107-132.
135. Shi, O., Morris, S.M. Jr, Zoghbi, H., Porter, C.W. & O'Brien, W.E. (2001) Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol. Cell. Biol. 21, 811-813.
136. Zwierzchowski, L., Czlonkowska, M. & Guszkiewicz, A. (1986) Effect of polyamine limitation on DNA synthesis and development of mouse preimplantation embryos in vitro. J. Reprod. Fertil. 76, 115-121.
137. Fozard, J.R., Grove, J., Part, M.L. & Prakash, N.J. (1979) Inhibition of early embryogenic development in mice by alpha-difluoromethyl ornithine, an enzyme-activated irreversible inhibitor of 1-ornithine decarboxylase. Br. J. Pharmacol. 66, 436P-437P.
138. Fozard, J.R., Part, M.-L., Prakash, N.J. & Grove, J. (1980) Inhibition of murine embryonic development by alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Eur. J. Pharmacol. 65, 379-391.
139. Pendeville, H., Carpino, N., Marine, J.-C., Takahashi, Y., Muller, M., Martial, J.A. & Cleveland, J.L. (2001) The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol. Cell. Biol. 21, 6549-6558.
140. Macrae, M., Plasterk, R.H. & Coffino, P. (1995) The ornithine decarboxylase gene of Caenorhabditis elegans: cloning, mapping and mutagenesis. Genetics 140, 517-525.
141. Macrae, M., Kramer, D.L. & Coffino, P. (1998) Developmental effect of polyamine depletion in Caenorhabditis elegans. Biochem. J. 333, 309-315.
142. Nishimura, K., Nakatsu, F., Kashiwagi, K., Ohno, H., Saito, T. & Igarashi, K. (2002) Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development. Genes Cells 7, 41-47.
143. Persson, K., Holm, I. & Heby, O. (1995) Cloning and sequencing of an
144. Bergeron, R.J., Weimar, W.R., Muller, R., Zimmerman, C.O., McCosar, B.H., Yao, H. & Smith, R.E. (1998) Effect of polyamine analogues on hypusine content in JURKAT T-cells. J. Med. Chem. 41, 3901-3908.
145. Korhonen, V.-P., Niiranen, K., Halmekytö, M., Pietilä, M., Diegelman, P., Parkkinen, J.J., Eloranta, T., Porter, C.W., Alhonen, L. & Jänne, J. (2001) Spermine deficiency resulting from targeted disruption of the spermine synthase gene in embryonic stem cells leads to enhanced sensitivity to anti-proliferative drugs. Mol. Pharmacol. 59, 231-238.
146. Seppänen, P. (1981) Some properties of the polyamine deprivation-inducible uptake system for methylglyoxal bis(guanylhydrazone) in tumor cells. Acta Chem. Scand. B35, 731-736.
147. van Maanen, J.M., Retel, J., de Vries, J. & Pinedo, H.M. (1988) Mechanism of action of antitumor drug etoposide: a review. J. Natl Cancer Inst. 80, 1526-1533.
148. Lorenz, B., Francis, F., Gempel, K., Boddrich, A., Josten, M., Schmahl, W., Schmidt, J., Lehrach, H., Meitinger, T. & Strom, T.M. (1998) Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene. Hum. Mol. Genet. 7, 541-547.
149. Lyon, M.F., Scriver, C.R., Baker, L.R., Tenenhouse, H.S., Kronick, J. & Mandla, S. (1986) The Gy mutation: another cause of X-linked hypophosphatemia in mouse. Proc. Natl Acad. Sci. USA 83, 4899-4903.
150. Beck, L., Soumounou, Y., Martel, J., Krishnamurthy, G., Gauthier, C., Goodyer, C.G. & Tenenhouse, H.S. (1997) Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J. Clin. Invest. 99, 1200-1209.
151. Nilsson, J., Gritli-Linde, A. & Heby, O. (2000) Skin fibroblasts from spermine synthase-deficient hemizygous gyro male (Gy/Y) mice overproduce spermidine and exhibit increased resistance to oxidative stress but decreased resistance to UV irradiation. Biochem. J. 352, 381-387.
152. Stefanelli, C., Bonavita, F., Stanic, I., Pignatti, C., Flamigni, F., Guarnieri, C. & Caldarera, C.M. (1999) Spermine triggers the activation of caspase-3 in a cell-free model of apoptosis. FEBS Lett. 451, 95-98.
153. Stefanelli, C., Pignatti, C., Tantini, B., Fattori, M., Stanic, I., Mackintosh, C.A., Flamigni, F., Guarnieri, C., Caldarera, C.M. & Pegg, A.E. (2001) Effect of polyamine depletion on caspase activation: a study with spermine synthase-deficient cells. Biochem. J. 355, 199-206.
154. Ikeguchi, Y., Mackintosh, C.A., McCloskey, D.E. & Pegg, A.E. (2003) Effect of spermine synthase on the sensitivity of cells to antitumor agents. Biochem. J. 373, 885-892.
155. Hamasaki-Katagiri, N., Katagiri, Y., Tabor, C.W. & Tabor, H. (1998) Spermine is not essential for growth of Saccharomyces cerevisiae: identification of the SPE4 gene (spermine synthase) and characterization of a spe4 deletion mutant. Gene 210, 195-201.
156. Hamasaki-Katagiri, N., Tabor, C.W. & Tabor, H. (1997) Spermidine biosynthesis in Saccharomyces cerevisae: polyamine requirement of a null mutant of the SPE3 gene (spermidine synthase). Gene 187, 35-43.
157. Panteleyev, A.A., Christiano, A.M., O'Brien, T.G. & Sundberg, J.P. (2000) Ornithine decarboxylase transgenic mice as a model for human atrichia with papular lesions. Exp. Dermatol 9, 146-151.
158. Rogers, S., Wells, R. & Rechsteiner, M. (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234, 364-368.
159. Tamori, A., Nishiguchi, S., Kuroki, T., Koh, N., Kobayashi, K., Yano, Y. & Otani, S. (1995) Point mutation of ornithine decarboxylase gene in human hepatocellular carcinoma 1. Cell. Res. 55, 3500-3503.
160. Maekawa, M., Sugano, K., Kashiwabara, H., Ushiama, M., Fujita, S., Ohkura, H. & Kakizoe, T. (1998) Point mutations of ornithine decarboxylase gene are an infrequent event in colorectal cancer but a missense mutation was found in a replication error positive patient with hMSH2 germline mutation. Jpn. J. Clin. Oncol. 28, 383-387.
161. Martinez, M.E., O'Brien, T.G., Fultz, K.E., Babbar, N., Yerushalmi, H., Qu, N., Guo, Y., Boorman, D., Einspahr, J., Alberts, D.S. & Gerner, E.W. (2003) Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc. Natl Acad. Sci. USA 100, 7859-7864.
162. Fultz, K.E. & Gerner, E.W. (2002) APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Mol. Carcinog. 34, 10-18.
163. Guo, Y., Harris, R.B., Rosson, D., Boorman, D. & O'Brien, T.G. (2000) Functional analysis of human ornithine decarboxylase alleles. Cancer Res. 60, 6314-6317.
164. Reddy, B.S., Nayini, J., Tokumo, K., Rigotty, J., Zang, E. & Kelloff, G. (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,1-α- difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50, 2562-2568.
165. Rao, C.V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G. & Reddy, B.S. (1991) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, a-difluoromethylornithine, 16α-fluoro-5-adrosten-17-one, and ellagic acid individually and in combination. Cancer Res. 51, 4528-4534.
166. Cason, A.L., Ikeguchi, Y., Skinner, C., Wood, T.C., Holden, K.R., Lubs, H.A., Martinez, F., Simensen, R.J., Stevenson, R.E., Pegg, A.E. & Schwartz, C.E. (2003) X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome. Eur. J. Hum. Genet. 11, 937-944.
167. 1-acetyltransferase (SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD). Hum. Genet. 111, 235-241.